Cornea/External Disease

Top Story

Allergan's TrueTear granted marketing authorization

April 25, 2017

The TrueTear intranasal tear neurostimulator has been granted marketing authorization from the FDA, according to an Allergan press release.

The hand-held stimulator is the first FDA-cleared device for temporarily increasing tear production during neurostimulation. The device has disposable tips and is inserted into the nasal cavity to induce the production of tears, the release said.

Microbial keratitis risk similar in contact lens patients vs. LASIK

April 24, 2017
The risk for microbial keratitis was similar between patients using contact lenses for 1 year compared with patients who had undergone LASIK, according to a study in the…

Shire studies SHP640 for infectious conjunctivitis

April 24, 2017
The first U.S. patient has been enrolled in a phase 3 clinical trial for Shire’s SHP640, a combination broad-spectrum antiseptic and corticosteroid being evaluated…
Perspectives on Glaucoma

Questionnaire addresses the concerns of glaucoma patients

April 20, 2017
A prospective, observational study based on a newly formulated questionnaire specifically addressed the concerns of glaucoma patients and identified demographic and…
CME

Glaucoma 2017: Controlling IOP and Promoting Adherence through Novel Therapeutics

This activity is supported by an educational grant from Aerie Pharmaceuticals, Inc.

Glaucoma is currently the second leading cause of blindness throughout the world. The goal of glaucoma treatment is to…
More »
Video
Meeting News

VIDEO: Prokera insertion an 'optometric friendly' procedure

April 4, 2017
More »
Featured
Vision Expo East

Vision Expo East

Video
Meeting News

VIDEO: Presenter - Blurry vision No. 1 symptom of dry eye

March 6, 2017
More »

Allergan's TrueTear granted marketing authorization

April 25, 2017
The TrueTear intranasal tear neurostimulator has been granted marketing authorization from the FDA, according to an Allergan press release. The…

Microbial keratitis risk similar in contact lens patients vs. LASIK

April 24, 2017
The risk for microbial keratitis was similar between patients using contact lenses for 1 year compared with patients who had undergone LASIK…

Shire studies SHP640 for infectious conjunctivitis

April 24, 2017
The first U.S. patient has been enrolled in a phase 3 clinical trial for Shire’s SHP640, a combination broad-spectrum antiseptic and…

Perspectives on Glaucoma

Questionnaire addresses the concerns of glaucoma patients

April 20, 2017
A prospective, observational study based on a newly formulated questionnaire specifically addressed the concerns of glaucoma patients and identified…

In the Journals

Study overturns hypothesis that mucin balls protect contact lens wearers

April 18, 2017
Mucin ball production in silicone hydrogel contact lens wearers may increase the risk of corneal infiltrative events in the long term, according to a…

Exfoliate the lid margin to prevent meibomian gland clogging

Primary Care Optometry News, April 2017
Joseph Hallak, OD, PhD, FAAO
The clinical signs and symptoms of dry eye disease seem to be contradictory. Some patients report symptoms of pain and itching much worse than the…

In the Journals

Longer duration of levofloxacin may lead to higher minimum inhibitory concentrations

April 18, 2017
Patients undergoing a longer duration of levofloxacin 1.5% administration after cataract surgery experienced higher minimum inhibitory concentrations…

In the Journals

Study shows efficacy of lifitegrast in relieving dry eye symptoms

April 17, 2017
Four weeks of treatment with lifitegrast 5% ophthalmic solution in patients with dry eye disease resulted in subjective relief of symptoms, according…

Palladium-103 brachytherapy deemed safe, pupil-sparing treatment

April 17, 2017
Iris melanoma treated with palladium-103 plaque brachytherapy showed patterns of regression that included decreased intrinsic tumor vascularity…

BLOG: How do androgen and estrogen affect dry eye?

April 13, 2017
I work in the optometry clinic at a VA hospital, so I see a lot of men older than 65 years, and the vast majority of my patients have meibomian gland…

More Headlines »
Advertisement
Advertisement